Mereo BioPharma Group PLC (MREO)
3.26
+0.15
(+4.82%)
USD |
NASDAQ |
May 03, 16:00
3.265
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Free Cash Flow: -21.55M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.55M |
| June 30, 2023 | -43.16M |
| December 31, 2022 | -48.83M |
| June 30, 2022 | -43.60M |
| December 31, 2021 | -7.071M |
| June 30, 2021 | -11.19M |
| December 31, 2020 | -38.62M |
| June 30, 2020 | -38.94M |
| Date | Value |
|---|---|
| December 31, 2019 | -60.22M |
| June 30, 2019 | -44.75M |
| December 31, 2018 | -29.40M |
| June 30, 2018 | -52.56M |
| December 31, 2017 | -46.55M |
| June 30, 2017 | -36.19M |
| December 31, 2016 | -36.60M |
| June 30, 2016 | -14.07M |
Free Cash Flow Range, Past 5 Years
-60.22M
Minimum
Dec 2019
-7.071M
Maximum
Dec 2021
-35.79M
Average
-41.05M
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -8.842M |
| NuCana PLC | -33.49M |
| TC BioPharm (Holdings) PLC | -13.42M |
| Adaptimmune Therapeutics PLC | -145.76M |
| Autolus Therapeutics PLC | -156.57M |
Free Cash Flow Related Metrics
| Free Cash Flow Yield | -5.01% |